Recent advances in the diagnosis of drug allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 4, 2007, Pages 299-303

  Romano, Antonino ^a,b,d   Demoly, Pascal ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d Unità di Allergologia   (Italy)

Author keywords

Drugs; Hypersensitivity; In vitro tests; Patch tests; Skin tests

Indexed keywords

AMINOPENICILLIN; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BETA LACTAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; HEPARIN; HIRUDIN; IMMUNOGLOBULIN E; INSULIN; IODINATED CONTRAST MEDIUM; MEROPENEM; MOXIFLOXACIN; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; PENICILLIN G; PENICILLOYL POLYLYSINE; ROCURONIUM;

ALLERGIC REACTION; ALLERGY TEST; ANAPHYLAXIS; ANTIBODY DETECTION; BASOPHIL; CELL ACTIVATION; CLINICAL FEATURE; CLINICAL IMMUNOLOGY; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IN VITRO STUDY; IN VIVO STUDY; INTRACUTANEOUS TEST; LYMPHOCYTE ACTIVATION; PATCH TEST; PENICILLIN ALLERGY; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; RADIOIMMUNOASSAY; REVIEW; SKIN TEST; TIME; URTICARIA; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BASOPHILS; BETA-LACTAMS; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOLOGIC TESTS; INTRADERMAL TESTS; LYMPHOCYTE ACTIVATION; SKIN TESTS;

EID: 34447341444     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328216f4d4     Document Type: Review

References (42)

1. Johansson S, Hourihane J, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-824.
2. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-693.
3. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity questionnaire. Allergy 1999; 54:999-1003.
4. Blanca M, Romano A, Torres MJ, et al. Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams. Clin Exp Allergy 2007; 37:166-173.
5. Macy E. Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 2006; 97:164-168.
6. Wong BB, Keith PK, Waserman S. Clinical history as a predictor of penicillin skin test outcome. Ann Allergy Asthma Immunol 2006; 97:169-174.
7. Jost BC, Wedner HJ, Bloomberg GR. Elective penicillin skin testing in a pediatric outpatient setting. Ann Allergy Asthma Immunol 2006; 97:807-812.
8. Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972.
9. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 1999; 83:665-700.
10. Bousquet PJ, Co-Minh HB, Arnoux B, et al. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of β-lactam allergy [letter]. J Allergy Clin Immunol 2005; 115:1314-1316.
11. Matheu V, Pérez-Rodriguez E, Sánchez-Machin I, et al. Major and minor determinants are high-performance skin tests in β-lactam allergy diagnosis [letter]. J Allergy Clin Immunol 2005; 116:1167-1168.
12. Romano A, Viola M, Bousquet JP, et al. A comparison of the performance of two penicillin reagent kits in the diagnosis of β-lactam hypersensitivity. Allergy 2007; 62:53-58.
13. Rodr?́guez-Bada JL, Montañez MI, Torres MJ, et al. Skin testing for immediate hypersensitivity to betalactams: comparison between two commercial kits. Allergy 2006; 61:947-951.
14. Romano A, Guéant-Rodriguez RM, Viola M, et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35:1234-1242.
15. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactions to cephalosporins: Evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006; 117:404-410.
16. Guéant JL, Guéant-Rodriguez RM, Viola M, et al. IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 2006; 12:3335-3345.
17. Romano A, Guéant-Rodriguez RM, Viola M, et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004; 141:16-22.
18. Gruchalla RS, Pirmohamed M. Antibiotic allergy. N Engl J Med 2006; 354:601-609.
19. Romano A, Viola M, Guéant-Rodriguez RM, et al. Imipenem in patients with immediate hypersensitivity to penicillins [letter]. N Engl J Med 2006; 354: 2835-2837.
20. Romano A, Viola M, Guéant-Rodriguez RM, et al. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007; 146:266-269. This article demonstrates that, contrary to the findings of a previous study, imipenem/cilastatin and meropenem do not cross-react with penicillins in almost all penicillin-allergic patients.
21. Co Minh HB, Bousquet PJ, Fontaine C, et al. Systemic reactions during skin tests with β-lactams: a risk factor analysis [letter]. J Allergy Clin Immunol 2006; 117:466-468.
22. Mertes PM, Laxenaire MC, Lienhart A, et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Invest Allergol Clin Immunol 2005; 15:91-101.
23. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60:150-158.
24. Guéant-Rodr?́guez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 2006; 12:3359-3372.
25. Kanny G, Pichler W, Morisset M, et al. T cell-mediated reactions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests. J Allergy Clin Immunol 2005; 115:179-185.
26. Kvedariene V, Martins P, Ruanet L, Demoly P. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period. Clin Exp Allergy 2006; 36:1072-1077.
27. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options. Allergy 2006; 61:1432-1440. This is a review that highlights the large number of hypersensitivity reactions to anticoagulants drugs and specifies the most useful diagnostic tools.
28. Fontaine C, Mayorga C, Bousquet PJ, et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of β-lactam allergy. Allergy 2007; 62:47-52.
29. Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004; 113:155-160.
30. Ebo DG, Bridts CH, Hagendorens MM, et al. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006; 61: 935-939.
31. Ebo DG, Sainte-Laudy J, Bridts CH, et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006; 61:1028-1039.
32. Sanz ML, Gamboa PM, Anté para I, et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32:277-286.
33. Torres MJ, Padial A, Mayorga C, et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004; 34:1768-1775.
34. Luque I, Leyva L, Torres MJ, et al. In vitro T-cell responses to β-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56:611-618.
35. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59:809-820.
36. Wu Y, Sanderson JP, Farrell J, et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 2006; 118:233-241. This article demonstrates the usefulness of the lymphocyte transformation test for evaluating hypersensitivity reactions to carbamazepine and assessing crossreactivity between this drug and its metabolites.
37. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones. Clin Exp Allergy 2006; 36:59-69.
38. Sachs B, Erdmann S, Malte Baron J, et al. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 2002; 32:736-744.
39. Merck HF. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 2005; 209:217-220.
40. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-863.
41. Wöhrl S, Vigl K, Stingl G. Patients with drug reactions: it is worth testing? Allergy 2006; 61:828-934.
42. Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001-1006.